Cytokine Signalling Forum


Sign in   Register
  • Home
  • Publications
  • Podcasts
  • Congresses
  • Educational Videos
  • Resources
  • CSF Live
  • Contact

Literature Highlights

Back to Publications To Literature Searches

Each month the CSF Steering Committee selects the latest published original articles on RA, PsA, and axSpA, focusing on those with data on therapeutic interventions and those that have clinical impact.

Literature review thumbnail: AxSpA Literature Highlights – March 2023
View Slides

AxSpA Literature Highlights – March 2023

more…

Keywords:

NSAIDs, MACE, Upadacitinib, HRQoL
Literature review thumbnail: RA Literature Highlights – March 2023
View Slides

RA Literature Highlights – March 2023

Tofacitinib, Baricitinib, Sarilumab, bDMARDs, tsDMARDs, BSRBR-RA

more…

Literature review thumbnail: AxSpA Literature Highlights – February 2023
View Slides

AxSpA Literature Highlights – February 2023

Bimekizumab, Secukinumab, TNF Inhibitor, bDMARD, Achilles Enthesitis

more…

Literature review thumbnail: RA Literature Highlights – February 2023
View Slides

RA Literature Highlights – February 2023

Tofacitinib, Baricitinib, MK2, JAK Inhibitor

more…

Literature review thumbnail: PsA Literature Highlights – February 2023
View Slides

PsA Literature Highlights – February 2023

Guselkumab, Tofacitinib, Ustekinumab, Herpes zoster, APEX

more…

Literature review thumbnail: AxSpA Literature Highlights – January 2023
View Slides

AxSpA Literature Highlights – January 2023

Bimekizumab, Safety, Efficacy, SpA

more…

Literature review thumbnail: PsA Literature Highlights – January 2023
View Slides

PsA Literature Highlights – January 2023

Bimekizumab, Secukinumab, Guselkumab, Safety, Efficacy, HRQoL, CIMPASI-1, CIMPASI-2, PSoHO, PsABIOnd, BE OPTIMAL, BE COMPLETE

more…

Literature review thumbnail: RA Literature Highlights – January 2023
View Slides

RA Literature Highlights – January 2023

more…

Literature review thumbnail: RA Literature Highlights – December 2022
View Slides

RA Literature Highlights – December 2022

bDMARDs, Baricitinib, Tofacitinib, Filgotinib

more…

Literature review thumbnail: PsA Literature Highlights – December 2022
View Slides

PsA Literature Highlights – December 2022

OMERACT, IL-17Ai, Deucravacitinib, IL‐23i

more…

‹ 1 2 3 4 ›

Developed under the auspices of:

University of Glasgow

With sponsorship and unrestricted educational grants from:

Abbvie logo Galapagos logo
Lilly logo Pfizer logo

Follow us on:

Twitter LinkedIn Facebook Apple Podcasts

© 2014 - 2023 | Supported by CESAS Medical. Legal | Contact | Site Map

APEX Award Winning logo
Health Awards logo